Stock Price Forecast

March 28, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Rezolute Inc chart...

About the Company

rezolute is a clinical stage biopharmaceutical company specializing in the development of innovative drug therapies to improve the lives of patients with metabolic and orphan diseases. rezolute is advancing a diversified pipeline including: rz358 (phase 2), an antibody for the ultra-orphan indication of congenital hyperinsulinism (chi) with an abbreviated path-to-market strategy; ab101 (phase 1), a once-weekly injectable basal insulin with the potential to transform the treatment landscape in diabetes management by reducing the therapeutic burden for patients and improving compliance; and rz402 (plan to file ind in h2 2018), a plasma kallikrein inhibitor (pki) targeting diabetic macular edema (dme). for more information, visit: www.rezolutebio.com.

CEO

Nevan Elam

Exchange

NASDAQ

Website

https://www.rezolutebio.com/

$M

Total Revenue

58

Employees

$101M

Market Capitalization

-2.28

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $RZLT News

Rezolute Reaches US$75m Market Cap Benefiting Insider Stock Buying

2d ago, source:

Rezolute, Inc. ( NASDAQ:RZLT ) insiders who bought shares over the past year were rewarded handsomely last week.

3 Stocks Insiders Are Buying That Analysts Love

2d ago, source: MarketBeat on MSN

It’s one thing for insiders to buy a stock, but it is something else if the market is also on board with the investment.

$1.5M Bet On This Penny Stock? Check Out These 4 Stocks Under $5 Insiders Are Aggressively Buying

on MSN ago, source:

The Dow Jones index closed lower by around 0.2% on Friday. When insiders purchase or sell shares, it indicates their ...

$17M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying

on MSN ago, source:

The Dow Jones index closed higher by over 300 points on Tuesday. When insiders purchase or sell shares, it indicates their ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...